{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T20:21:40Z","timestamp":1789590100610,"version":"build-2803163510"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","award":["SD2210"],"award-info":[{"award-number":["SD2210"]}],"id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008549","name":"Shanxi Medical University","doi-asserted-by":"publisher","award":["XD2117"],"award-info":[{"award-number":["XD2117"]}],"id":[{"id":"10.13039\/501100008549","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ejphar.2026.179012","type":"journal-article","created":{"date-parts":[[2026,5,24]],"date-time":"2026-05-24T00:33:43Z","timestamp":1779582823000},"page":"179012","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Trifluoperazine induces ferroptosis in acute myeloid leukemia by suppressing the Nrf2\/SLC7A11\/GPX4 axis"],"prefix":"10.1016","volume":"1029","author":[{"given":"Jing","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanfang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaofang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianbing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohua","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianqing","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanggang","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ejphar.2026.179012_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s13045-023-01424-6","article-title":"Recent advances in targeted therapies in acute myeloid leukemia","volume":"16","author":"Bhansali","year":"2023","journal-title":"J. Hematol. Oncol."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179012_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1038\/s41571-020-00462-0","article-title":"Broadening horizons: the role of ferroptosis in cancer","volume":"18","author":"Chen","year":"2021","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.ejphar.2026.179012_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155288","article-title":"Dual role of Nrf2\/HO-1 pathway in Z-ligustilide-induced ferroptosis against AML cells","volume":"124","author":"Chen","year":"2024","journal-title":"Phytomedicine"},{"issue":"5","key":"10.1016\/j.ejphar.2026.179012_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.tips.2025.03.005","article-title":"Repurposing trifluoperazine for glioblastoma treatment","volume":"46","author":"De Silva","year":"2025","journal-title":"Trends Pharmacol. Sci."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179012_bib5","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41580-023-00585-z","article-title":"Autophagy and autophagy-related pathways in cancer","volume":"24","author":"Debnath","year":"2023","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2026.179012_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155282","article-title":"Mangiferin attenuates osteoporosis by inhibiting osteoblastic ferroptosis through Keap1\/Nrf2\/SLC7A11\/GPX4 pathway","volume":"124","author":"Deng","year":"2024","journal-title":"Phytomedicine"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179012_bib7","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1038\/s41420-024-02148-3","article-title":"Bithionol eliminates acute myeloid leukaemia stem-like cells by suppressing NF-\u03baB signalling and inducing oxidative stress, leading to apoptosis and ferroptosis","volume":"10","author":"Dias","year":"2024","journal-title":"Cell Death Discov."},{"key":"10.1016\/j.ejphar.2026.179012_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115185","article-title":"Ozone pretreatment alleviates ischemiareperfusion injury-induced myocardial ferroptosis by activating the Nrf2\/Slc7a11\/Gpx4 axis","volume":"165","author":"Ding","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2026.179012_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2020.100713","article-title":"Repurposing old drugs to fight multidrug resistant cancers","volume":"52","author":"Dini\u0107","year":"2020","journal-title":"Drug Resist. Updates"},{"issue":"1","key":"10.1016\/j.ejphar.2026.179012_bib10","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179012_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1038\/s41419-018-1046-3","article-title":"The antipsychotic agent trifluoperazine hydrochloride suppresses triple-negative breast cancer tumor growth and brain metastasis by inducing G0\/G1 arrest and apoptosis","volume":"9","author":"Feng","year":"2018","journal-title":"Cell Death Dis."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179012_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.tips.2024.03.005","article-title":"AML treatment: conventional chemotherapy and emerging novel agents","volume":"45","author":"Forsberg","year":"2024","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.ejphar.2026.179012_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101955","article-title":"Mitochondrial dysfunction in aging","volume":"88","author":"Guo","year":"2023","journal-title":"Ageing Res. Rev."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179012_bib14","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41575-024-00931-2","article-title":"Mitochondrial function and gastrointestinal diseases","volume":"21","author":"Haque","year":"2024","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ejphar.2026.179012_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2024.110562","article-title":"Effects of dopamine receptor antagonists and radiation on mouse neural stem\/progenitor cells","volume":"201","author":"He","year":"2024","journal-title":"Radiother. Oncol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179012_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.3928\/02793695-20151223-01","article-title":"Trifluoperazine: a sprightly old drug","volume":"54","author":"Howland","year":"2016","journal-title":"J. Psychosoc. Nurs. Ment. Health Serv."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179012_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10051046","article-title":"Trifluoperazine and its analog suppressed the tumorigenicity of non-small cell lung cancer cell; applicability of antipsychotic drugs to lung cancer treatment","volume":"10","author":"Jeong","year":"2022","journal-title":"Biomedicines"},{"issue":"4","key":"10.1016\/j.ejphar.2026.179012_bib18","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","article-title":"Ferroptosis: mechanisms, biology and role in disease","volume":"22","author":"Jiang","year":"2021","journal-title":"Nat. Rev. Mol. Cell Biol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179012_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110448","article-title":"CDK\/cyclin dependencies define extreme cancer cell-cycle heterogeneity and collateral vulnerabilities","volume":"38","author":"Knudsen","year":"2022","journal-title":"Cell Rep."},{"issue":"8","key":"10.1016\/j.ejphar.2026.179012_bib20","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s13238-020-00789-5","article-title":"Cystine transporter SLC7A11\/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy","volume":"12","author":"Koppula","year":"2021","journal-title":"Protein Cell"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179012_bib21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1053\/j.semdp.2023.04.002","article-title":"Updates in molecular genetics of acute myeloid leukemia","volume":"40","author":"Kurzer","year":"2023","journal-title":"Semin. Diagn. Pathol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179012_bib22","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.ccell.2024.03.011","article-title":"The roles of ferroptosis in cancer: tumor suppression, tumor microenvironment, and therapeutic interventions","volume":"42","author":"Lei","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2026.179012_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2024.103087","article-title":"METTL17 coordinates ferroptosis and tumorigenesis by regulating mitochondrial translation in colorectal cancer","volume":"71","author":"Li","year":"2024","journal-title":"Redox Biol."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179012_bib24","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/s41419-020-2298-2","article-title":"Ferroptosis: past, present and future","volume":"11","author":"Li","year":"2020","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179012_bib25","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.7150\/ijbs.83348","article-title":"The crosstalk between ferroptosis and mitochondrial dynamic regulatory networks","volume":"19","author":"Li","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2026.179012_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.117966","article-title":"Lizhong decoction ameliorates ulcerative colitis by inhibiting ferroptosis of enterocytes via the Nrf2\/SLC7A11\/GPX4 pathway","volume":"326","author":"Li","year":"2024","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179012_bib27","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s13045-021-01062-w","article-title":"Emerging agents and regimens for AML","volume":"14","author":"Liu","year":"2021","journal-title":"J. Hematol. Oncol."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179012_bib28","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1038\/s41419-023-06154-8","article-title":"Autophagy: regulator of cell death","volume":"14","author":"Liu","year":"2023","journal-title":"Cell Death Dis."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179012_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1038\/s41556-024-01425-8","article-title":"Exploiting ferroptosis vulnerabilities in cancer","volume":"26","author":"Nakamura","year":"2024","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179012_bib30","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1016\/S1470-2045(23)00452-7","article-title":"Fixed-duration ibrutinib-venetoclax versus chlorambucil-obinutuzumab in previously untreated chronic lymphocytic leukaemia (GLOW): 4-year follow-up from a multicentre, open-label, randomised, phase 3 trial","volume":"24","author":"Niemann","year":"2023","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.ejphar.2026.179012_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.critrevonc.2024.104349","article-title":"The crosstalk between oncogenic signaling and ferroptosis in cancer","volume":"197","author":"Pang","year":"2024","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"9","key":"10.1016\/j.ejphar.2026.179012_bib32","doi-asserted-by":"crossref","first-page":"15756","DOI":"10.1002\/jcb.28845","article-title":"Trifluoperazine as an alternative strategy for the inhibition of tumor growth of colorectal cancer","volume":"120","author":"Qian","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"21","key":"10.1016\/j.ejphar.2026.179012_bib33","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1200\/JCO-25-00758","article-title":"Zanubrutinib and venetoclax for patients with treatment-Na\u00efve chronic lymphocytic leukemia\/small lymphocytic lymphoma with and without Del(17p)\/TP53 mutation: SEQUOIA arm D results","volume":"43","author":"Shadman","year":"2025","journal-title":"J. Clin. Oncol."},{"issue":"11","key":"10.1016\/j.ejphar.2026.179012_bib34","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1158\/2159-8290.CD-24-1043","article-title":"ALKBH1 drives tumorigenesis and drug resistance via tRNA-decoding reprogramming and codon-biased translation","volume":"15","author":"Shen","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.ejphar.2026.179012_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cbi.2024.110904","article-title":"Trifluoperazine activates AMPK\/mTOR\/ULK1 signaling pathway to induce mitophagy in osteosarcoma cells","volume":"392","author":"Shen","year":"2024","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.ejphar.2026.179012_bib36","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.freeradbiomed.2025.03.031","article-title":"SR-B1 deficiency suppresses progression in acute myeloid leukemia via ferroptosis and reverses resistance to venetoclax","volume":"233","author":"Shi","year":"2025","journal-title":"Free Radic. Biol. Med."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179012_bib37","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/cac2.12520","article-title":"Cell fate regulation governed by p53: friends or reversible foes in cancer therapy","volume":"44","author":"Song","year":"2024","journal-title":"Cancer Commun."},{"issue":"2","key":"10.1016\/j.ejphar.2026.179012_bib38","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1038\/s41422-020-00441-1","article-title":"Ferroptosis: molecular mechanisms and health implications","volume":"31","author":"Tang","year":"2021","journal-title":"Cell Res."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179012_bib39","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.humimm.2021.07.005","article-title":"Dopamine promotes the progression of AML via activating NLRP3 inflammasome and IL-1\u03b2","volume":"82","author":"Wang","year":"2021","journal-title":"Hum. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179012_bib40","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41418-023-01239-5","article-title":"TRIM3 facilitates ferroptosis in non-small cell lung cancer through promoting SLC7A11\/xCT K11-linked ubiquitination and degradation","volume":"31","author":"Wang","year":"2024","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.ejphar.2026.179012_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.freeradbiomed.2024.01.005","article-title":"Propionate promotes ferroptosis and apoptosis through mitophagy and ACSL4-mediated ferroptosis elicits anti-leukemia immunity","volume":"213","author":"Wei","year":"2024","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2026.179012_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.105295","article-title":"Repurposing of antipsychotic trifluoperazine for treating brain metastasis, lung metastasis and bone metastasis of melanoma by disrupting autophagy flux","volume":"163","author":"Xia","year":"2021","journal-title":"Pharmacol. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179012_bib43","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/s41392-024-01769-5","article-title":"Ferroptosis in cancer: from molecular mechanisms to therapeutic strategies","volume":"9","author":"Zhou","year":"2024","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926004942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T12:14:33Z","timestamp":1784808873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926004942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":43,"alternative-id":["S0014299926004942"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179012","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trifluoperazine induces ferroptosis in acute myeloid leukemia by suppressing the Nrf2\/SLC7A11\/GPX4 axis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179012"}}